Paul Sondel, MD, PhD and Team Awarded U54 Subaward from NIH/NCI and Children's Hospital of Philadelphia

Paul Sondel, MD, PhD
Paul Sondel, MD, PhD

Congratulations to Paul Sondel, MD, PhD, Subaward Principal Investigator, and UW Team Members, Amy Erbe-Gurel, PhD, Jacquelyn Hank, PhD, Zachary Morris, MD, PhD, and Alexander Rakhmilevich, MD, PhD, for their recent subaward through the Children's Hospital of Philadelphia and supported by the National Institutes of Health/National Cancer Institute (NIH/NCI). This U54 award was made through the Pediatric Immunotherapy Discovery and Development Network, as part of the Beau Biden Cancer Moonshot Initiative, and will provide ~$2.1 million to the UW over 5 years. This collaborative multi-institutional consortium, entitled, "Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers," has a total award of $12.1 million and is led by overall Principal Investigator, Dr. John Maris at the Center for Childhood Cancer Research at Children's Hospital of Philadelphia, the Lead Institution, and Co-PI Dr. Crystall Mackall at Stanford University. Dr. Sondel and his team will lead Project 3, "Discovery and development of pediatric cancer antigen targets recognized by adaptive immune response," as well as support two additional projects of the cooperative agreement.